SCHEMBL667611

SCHEMBL667611

CCCCCCCCCCC(Cc1ccccc1)[C](C)C

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.58
MMP2 P08253 17/20 0.50
MMP3 P08254 12/20 0.50
MMP1 P03956 10/20 0.50
MMP7 P09237 6/20 0.47
FOLH1 Q04609 1/20 0.46
CNR2 P34972 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4914035 1.00 CSNK1E (0.58) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL4926240 1.00 CSNK1E (0.58) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL717704 1.00 CSNK1E (0.58) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL3400024 1.00 CSNK1E (0.58) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL2782163 1.00 CSNK1E (0.58) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL11624296 0.93 CSNK1E (0.49) CSNK1EMMP2MMP3MMP1FOLH1
SCHEMBL5017227 0.87 MMP2 (0.57) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL28211408 0.87 MMP2 (0.57) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL10801653 0.85 CSNK1E (0.56) CSNK1EMMP2MMP3MMP1MMP7
SCHEMBL10955140 0.85 FOLH1 (0.66) CSNK1EMMP2MMP3MMP1MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954518-A1 NEW POLYDYNAMIC CHEMICAL COMPOSITION OF MULTIPLE APPLICATIONS AND METHOD OF PREPARATION THEREOF Venetsianos, Timoleon (GR) 1999-11-10 EP claimed
WO-1998035933-A1 NEW POLYDYNAMIC CHEMICAL COMPOSITION OF MULTIPLE APPLICATIONS AND METHOD OF PREPARATION THEREOF VENETSIANOS TIMOLEON (GR) 1998-08-20 WO claimed
US-20240156964-A1 IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY THE ARIZONA BOARD OF REGENTS 2024-05-16 US disclosed
US-11786597-B2 Ionic liquids for transdermal drug delivery THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-17 US disclosed
US-20230310528-A1 DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS OPTIMI HEALTH CORP (CA) 2023-10-05 US disclosed
US-20230002676-A1 TREATMENT LIQUID AND TREATMENT LIQUID CONTAINER FUJIFILM CORPORATION (JP) 2023-01-05 US disclosed
US-20200352164-A1 ANTIMICROBIAL PRESERVATIVE COMPOSITIONS SHARON PERSONAL CARE LTD. (IL) 2020-11-12 US disclosed
US-10449254-B2 Ionic liquids for transdermal drug delivery THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-10-22 US disclosed
US-10392560-B2 Compositions and methods for selectively etching titanium nitride ENTEGRIS, INC. (US) 2019-08-27 US disclosed
US-20170260449-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE TRUIST BANK, AS NOTES COLLATERAL AGENT 2017-09-14 US disclosed
US-9546321-B2 Compositions and methods for selectively etching titanium nitride ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2017-01-17 US disclosed
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION 2008-10-09 US disclosed
US-7303876-B2 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases APPLERA CORPORATION (US) 2007-12-04 US disclosed
US-20050009045-A1 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases APPLERA CORPORATION 2005-01-13 US disclosed
EP-0954518-A1 NEW POLYDYNAMIC CHEMICAL COMPOSITION OF MULTIPLE APPLICATIONS AND METHOD OF PREPARATION THEREOF Venetsianos, Timoleon (GR) 1999-11-10 EP disclosed
WO-1998035933-A1 NEW POLYDYNAMIC CHEMICAL COMPOSITION OF MULTIPLE APPLICATIONS AND METHOD OF PREPARATION THEREOF VENETSIANOS TIMOLEON (GR) 1998-08-20 WO disclosed
CN-1117728-A Substituted oxazole compounds BAYER AG (DE) 1996-02-28 CN disclosed
EP-0299191-B1 MIXTURE OF FUNGICIDALLY ACTIVE AGENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1992-03-04 EP disclosed
EP-0299191-A1 Mixture of fungicidally active agents Henkel Kommanditgesellschaft auf Aktien (DE) 1989-01-18 EP disclosed
EP-0258737-A2 Antimicrobial mixtures Henkel Kommanditgesellschaft auf Aktien (DE) 1988-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS GLO1, ESD, GLB1 CSNK1E 1680/4885MMP2 1338/4885MMP3 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.